Document Migration

WHITE PAPERS AND CASE STUDIES

• 5 Must-Haves For Electronic Batch Records In Pharma Manufacturing

  Pharma companies still relying on paper-based manufacturing are falling behind. Discover how digital transformation boosts efficiency, reduces errors, and ensures compliance in this essential shift toward smarter operations.

• 4 Key FSP Considerations To Optimize Drug Development

  Review several benefits of using a functional service provider model and what four things to consider before choosing a partner to help meet challenging drug development timelines.

• How Early-Stage Planning Strategies Are Optimizing Drug Development

  Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.

• Better Fleet Management For Utilities Field Vehicles: How Mobile Technology Can Help

  In this white paper, we’ll explore some of the challenges of maintaining and managing fleet vehicles for utilities workers in the field—and demonstrate how mobile technology can help fleet managers keep crews working productively and significantly reduce unexpected downtime.

• Containment Solutions To Help Emerging Biologic Companies

  Set up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.

• Antibody-Drug Conjugates – Catalysts For Chemistry

  Review the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development.

• Innovative FSP Solutions For Biopharma Growth And Transition

  To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.

• Insights And Effective Strategies For A Successful Technology Transfer

  Discover key strategies for seamless pharmaceutical technology transfers that accelerate time to market, ensure product quality, and meet regulatory standards across the drug lifecycle.

• From Phase I In Australia To A Global Phase III

  With some help, see how one California-based biotech company was able to get its patients on treatment by the end of the fiscal year and identify additional opportunities to streamline processes and leverage document/process standards.

• Buffers And Process Liquids For Biopharmaceutical Production: Considerations For Scale-Up And Outsourcing

  For small and midsize biopharmaceutical organizations, outsourcing buffer and process liquid preparation, quality testing, and storage could significantly streamline operations and reduce regulatory risk.

• Digital/Hybrid Trials Deliver Greater ROI Than Traditional Trials

  In this paper, Tufts CSDD outlines why and how modernized clinical trials can drive greater savings (up to $40,000,000 per study) than traditional trials.

• Rethink What You Should Expect From Your System: Modern Batch Solution

  Today’s dynamic manufacturing climate presents multiple challenges, forcing manufacturers to compare traditional and modern batch and rethink what to expect when choosing a system.